Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Retinyl Palmitate.
A preformed Vitamin A ester that undergoes enzymatic hydrolysis to retinol and subsequent oxidation to retinoic acid, primarily utilized for epidermal cell turnover, collagen synthesis, and visual cycle maintenance.
445354
286.5 g/mol
5.7
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Retinyl Palmitate across standard consumer modalities.
Retinyl palmitate is highly susceptible to oxidative degradation in dry powder formats, requiring nitrogen flushing or beadlet encapsulation with antioxidants to maintain potency.
The lipophilic nature of the ester requires precise emulsification within the pectin matrix to prevent oil-bleeding and ensure uniform dosage distribution.
Low payload capacity and the requirement for lipid-based solubilizers make it difficult to achieve therapeutic dosages while maintaining the structural integrity and rapid dissolution of the thin-film matrix.
Ready to launch a product featuring Retinyl Palmitate? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Retinyl Palmitate extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Retinyl Palmitate payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation